HUA TENG

Guangzhou Huateng Biomedical Technology Co., Ltd. is a national high-tech enterprise integrating the research and development, production of experimental animal models, and contract research organization (CRO) services for biopharmaceuticals. The company focuses on large animal models, with gene-edited animal models and organoid models as its specialties, offering services covering scientific research, preclinical drug evaluation (efficacy/pharmacokinetics/toxicology studies), preclinical evaluation of medical devices (large animal experiments/biocompatibility), and third-party testing. The company has established experimental centers in Guangzhou, Shenzhen, Hong Kong, Xiamen, and Chongqing, with a total area exceeding 15,000 square meters, investing nearly 100 million yuan in advanced scientific research equipment. It possesses an animal model resource bank of over 200 types, holds AAALAC international accreditation without deficiencies, CNAS laboratory accreditation, and more than 200 CMA-certified projects. It complies with multiple international standards such as FDA-GLP and OECD-GLP systems and is a leading one-stop non-clinical research CRO platform in China.